期刊文献+

药物基因组学与质子泵抑制剂的合理应用 被引量:5

下载PDF
导出
摘要 随着人们生活方式的不断变化,主要因吸烟、饮酒、情绪紧张、药物刺激等因素引起的消化性溃疡发病率逐渐增高,成为一种常见病和多发病,给患者带来极大的痛苦,导致患者生活质量下降。基于以上原因,消化性溃疡的治疗在临床上越来越受到关注和重视。作为治疗胃和十二指肠溃疡、胃食管反流病、吻合口溃疡等酸相关性疾病的首选药物,质子泵抑制剂在医院临床上得到了广泛应用。为了进一步研讨质子泵抑制剂的临床应用进展,促进质子泵抑制剂的合理选用,本刊编辑部于2011年5月7日在北京组织召开了"质子泵抑制剂的合理使用学术研讨会"。会议由北京大学第三医院林三仁教授主持,解放军海军总医院孙忠实教授、北京大学第一医院王蔚虹教授分别作了题为"药物基因组学与质子泵抑制剂的合理应用"、"质子泵抑制剂临床应用进展"的专题发言。北京地区消化及药学领域30余位专家出席会议并围绕质子泵抑制剂与其他药物的相互作用,如何为长期使用质子泵抑制剂患者选择合适的剂量和疗程,避免药物滥用以及根据个体基因的不同而选取合适的药物等问题进行了讨论。
作者 孙忠实
出处 《中国医院用药评价与分析》 2011年第6期481-483,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
  • 相关文献

参考文献13

  • 1Li XQ, Andersson TB, AhlstrSm, et al. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities [ J ]. Drug Metab Dispos ,2004 ,32 ( 8 ) : 821.
  • 2Gilard M, Arnaud B, Cornily JC, et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA( Omeprazole CLopidogrel Aspirin) study[ J]. J Am Coll Cardiol,2008,5 l ( 3 ) :256.
  • 3Rassen JA, Choudhry NK, Avorn J, et al. Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome [ J ~. Circulation, 2009,120 ( 23 ) :2322.
  • 4Laine L, Hennekens C. Proton pump inhibitor and clopidogrel interaction: fact or fiction [ J ]. Am J Gastroenterol,2010,105 ( 1 ) :34.
  • 5Bhatt DL, Cryer BL, Contant CF,et al. Clopidogrel with or without omeprazole in coronary artery disease[ J~. N Engl J Med,2010,363(20) :1909.
  • 6Shuldiner AR, O'Connell JR, Bliden KP, et al. Association of cytochrome P4s0 2Cl9 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy [ J 1. JAMA, 2009,302 ( 8 ) : 849.
  • 7Stockl KM, Le L, Zakharyan A, et al. Risk of rehospitalization for patients using c|opidogrel with a proton pump inhibitor [ J ]. Arch Intern Med, 2010, 170 (8) :704.
  • 8Huang CC, Chen YC, Leu liB, et al. Risk of adverse outcomes in Taiwan associated with concomitant use of clopidogrel and proton pump inhibitors in patients who received percutaneous coronary intervention [ J 1. Am J Cardio1,2010,105 ( 12 ) : 1705.
  • 9Ho PM, Maddox TM, Wang L, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome [ J ]. JAMA, 301 ( 9 ) :937.
  • 10Shi S, Klotz U. Proton pump inhibitors : an update of theirclinical and pharmacokinetics [ J ]. Eur J ClinPharmacol, 2008,64 ( 10 ) : 935.

同被引文献41

  • 1朱珠,蔡乐.质子泵抑制剂的安全性与合理应用[J].药物不良反应杂志,2005,7(2):81-90. 被引量:56
  • 2唐珙.某医院治疗消化性溃疡药物的利用分析及质子泵抑制剂应用合理性评价[D].中南大学,2011.
  • 3O'Donoghue ML. CYP2C19 genotype and proton pump inhibitors in clo- pidogrel -treated patients: does it take two to tango? [J]. Circulation, 2011, 123 (5): 468-470.
  • 4Ntaios G, Chatzinikolaou A, Kaiafa G, et al. Evaluation of use of proton pump in- hibitors in Greece[J]. Eur J Intern Med, 2009, 20(2):171-173.
  • 5Chariot M, Ahlehoff O, Norgaard ML, et al. Proton-pump inhibitors are associated with increased cardiovascular risk inde- pendent of clopidogrel use: a nationwide cohort study[J]. Ann Intern Med, 2010, 153(6): 378-386.
  • 6Matsuyama J,Tsuji K,Doyama H,et al.Hypomagnesemia associated with a proton pump inhibitor[J].Intern Med,2012,51(16):2231-2234.
  • 7Katz PO,Gerson LB,Vela MF.Guidelines for the diagnosis and management of gastroesophageal reflux disease[J].Am J Gastroenterol,2013,108(3):308-328.
  • 8Ishikawa S,Inaba T,Mizuno M,et al.Incidence of serious upper gastrointestinal bleeding in patients taking non-steroidal antiinflammatory drugs in Japan[J].Acta Med Okayama,2008,62(1):29-36.
  • 9第三次全国幽门螺杆菌感染若干问题共识报告[J].中华内科杂志,2008,47(4):346-349. 被引量:80
  • 10陈会松,叶国良,程德希,盛红,谢韵琴.质子泵抑制剂干预疗程对非甾体类抗炎药溃疡性再出血的影响[J].实用医学杂志,2009,25(11):1769-1770. 被引量:18

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部